Monocyte/HDL Cholesterol Ratios as a New Inflammatory Marker in Patients with Schizophrenia
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Purpose: Monocyte/HDL cholesterol ratio (MHR) is a novel inflammatory marker that is used as a prognostic factor for cardiovascular diseases and has been studied in many diseases. The aim of this study was to investigate the role of inflammatory factors in schizophrenia patients by examining MHR levels and to compare schizophrenia patients and healthy controls in terms of cardiovascular disease risk. Method: A total of 135 participants between the ages of 18–65, 85 diagnosed with schizophrenia, and 50 healthy individuals in the control group were included in this cross-sectional study. Venous blood samples were taken from the participants and CBC parameters and lipid profiles were analyzed. The sociodemographic and clinical data form and positive and negative symptoms scale (PANSS) were administered to all participants. Results: Although monocyte levels were significantly higher in the patient group, HDL-C levels were lower at significant levels. MHR was found to be higher in the patient group compared to the control group at significant levels. When compared to the control group, total cholesterol, triglyceride, WBC, neutrophil, basophil, and platelet levels were higher in the patient group at significant levels, and RBC, hemoglobin, and hematocrit levels were significantly lower. Conclusion: The elevated MHR in patients with schizophrenia may contribute to our understanding that inflammation plays important roles in the pathophysiology of schizophrenia. Additionally, knowing the levels of MHR and considering the recommendations, such as diet and exercise, in the treatment approaches made us think that it might be beneficial in protecting schizophrenia patients against cardiovascular diseases and early death.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MHR in schizophrenia 19,22,68,69 , NHR, PHR and LHR in schizophrenia 19,22 , NLR and MHR in bipolar depression 19,36,37 , MHR in unipolar depression 70 and MHR in post-stroke depression 71 were found higher.”
Citations
Cites
Polazzi, E., Mengoni, I., Caprini, M., Peña-Altamira, E., Kurtys, E., & Monti, B. (2013) · Neurosignals · doi:10.1159/000337115 · Cited by 8,994
Second-Generation (Atypical) Antipsychotics and Metabolic Effects: A Comprehensive Literature Review
Newcomer, J. W. (2005) · CNS Drugs · doi:10.2165/00023210-200519001-00001 · Cited by 1,340 · cited 1×
“In other words, this risk increases with the course of the disease and the treatments used [32].”
BackgroundBrain inflammation and adult neurogenesis: The dual role of microglia
Ekdahl, C. T., Kokaia, Z., & Lindvall, O. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.06.052 · Cited by 801 · cited 1×
“It was reported that microglia, which are the monocytes in the brain, can increase inflammatory activation abnormally, affect neuronal growth factors, or be harmful to neurogenesis and synaptogenesis by producing neurotoxic factors and cytokines [5].”
BackgroundSchizophrenia, “Just the Facts”: What we know in 2008
Tandon, R., Keshavan, M. S., & Nasrallah, H. A. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.01.022 · Cited by 409 · cited 2×
“In addition, psychiatric diseases and neurological diseases have been detected with artificial intelligence in the literature [1].”
BackgroundBeumer, W., Gibney, S. M., Drexhage, R. C., Pont-Lezica, L., Doorduin, J., Klein, H. C., Steiner, J., Connor, T. J., Harkin, A., Versnel, M. A., et al. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0212100 · Cited by 347 · cited 1×
“It was also reported that activation of microglia and circulating monocytes are elevated in schizophrenia patients and in animal models with schizophrenia-like behaviors, which has important effects on the growth, development, and function of neuronal circuits in the brain [6].”
BackgroundMonocyte‐to‐HDL‐cholesterol ratio as a prognostic marker in cardiovascular diseases
Ganjali, S., Gotto, A. M., Ruscica, M., Atkin, S. L., Butler, A. E., Banach, M., & Sahebkar, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27028 · Cited by 313 · cited 1×
“According to recent studies, MHR, which is easy to use, non-invasive, and can be obtained with a simple calculation method, was reported to be a prognostic factor in cardiovascular diseases in addition to being a new inflammatory marker [30].”
MethodSerum amyloid A impairs the antiinflammatory properties of HDL
Han, C. Y., Tang, C., Guevara, M. E., Wei, H., Wietecha, T., Shao, B., Subramanian, S., Omer, M., Wang, S., O’Brien, K. D., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci83475 · Cited by 171 · cited 2×
“Monocytes and macrophages play important roles in the synthesis and release of pro-inflammatory and prooxidant cytokines [4].”
Aiello, R. J., Brees, D., & Francone, O. L. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000054661.21499.fb · Cited by 146
Negi, G., Kumar, A., Joshi, R. P., & Sharma, S. S. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.03.087 · Cited by 144 · cited 1×
“It is considered today that the MHR may be a new marker of inflammation and oxidative stress because of the anti-inflammatory and antioxidant effects of HDL-C as well as the pro-inflammatory effect of monocytes [12].”
BackgroundWysokiński, A., Strzelecki, D., & Kłoszewska, I. (2015) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2015.04.004 · Cited by 120 · cited 1×
“It was reported in a meta-analysis conducted in schizophrenia patients with first-episode psychosis who did not use medication that HDL-C and total cholesterol ratios were low, and triglyceride ratios were significantly higher [26].”
ResultPrimate brain pattern-based automated Alzheimer's disease detection model using EEG signals
Doğan, Ş., Bayğın, M., Taşçı, B., Loh, H. W., Barua, P. D., Tuncer, T., Tan, R., & Acharya, U. R. (2022) · Cognitive Neurodynamics · doi:10.1007/s11571-022-09859-2 · Cited by 114
Impaired monocyte activation in schizophrenia
Müller, N., Wagner, J. K., Krause, D., Weidinger, E., Wildenauer, A., Obermeier, M., Dehning, S., Gruber, R., & Schwarz, M. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2011.12.049 · Cited by 107 · cited 1×
“Studies that investigate the roles of inflammation in schizophrenia reported that the number of monocytes increases, but monocyte functions are impaired and an increased proinflammatory cytokine signal significantly impairs emotional, cognitive, and social functions, increasing sensitivity to environmental risk factor…”
BackgroundTaşçı, G., Loh, H. W., Barua, P. D., Bayğın, M., Taşçı, B., Doğan, Ş., Tuncer, T., Palmer, E. E., Tan, R., & Acharya, U. R. (2022) · Knowledge-Based Systems · doi:10.1016/j.knosys.2022.110190 · Cited by 105
Demir, F., Akbulut, Y., Taşçı, B., & Demir, K. (2022) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2022.104424 · Cited by 96
MAÇİN, G., Taşçı, B., Taşçı, İ., Faust, O., Barua, P. D., Doğan, Ş., Tuncer, T., Tan, R., & Acharya, U. R. (2022) · Applied Sciences · doi:10.3390/app12104920 · Cited by 75
Massrali, A., Adhya, D., Srivastava, D. P., Baron-Cohen, S., & Kotter, M. R. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.834058 · Cited by 73 · cited 1×
“Additionally, it was reported that cytokines, whose blood levels increase after viral or bacterial infections during pregnancy, cross the placenta affecting the brain tissue of the fetus, disrupting the normal neurodevelopmental process, which plays roles in the development of schizophrenia [7].”
BackgroundInflammatory, cardio-metabolic and diabetic profiling of chronic schizophrenia
Balõtšev, R., Koido, K., Vasar, V., Janno, S., Kriisa, K., Mahlapuu, R., Ljubajev, U., Parksepp, M., Veiksaar, P., Volke, V., et al. (2017) · European Psychiatry · doi:10.1016/j.eurpsy.2016.05.010 · Cited by 64 · cited 1×
“It was shown in another study with cytokines that low-level inflammation increases the cardiometabolic risk [37].”
ResultDemir, F., & Taşçı, B. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11121276 · Cited by 59
Early Environmental Upheaval and the Risk for Schizophrenia
Paquin, V., Lapierre, M., Veru, F., & King, S. (2021) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-081219-103805 · Cited by 53 · cited 1×
“It is considered that exposure to environmental factors from the fetal period may cause neurodevelopmental disorders by increasing the abnormal immune response and increasing the risk of developing schizophrenia [2].”
BackgroundDeep feature extraction based brain image classification model using preprocessed images: PDRNet
Taşçı, B., & Taşçı, İ. (2022) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2022.103948 · Cited by 53
A novel ternary pattern-based automatic psychiatric disorders classification using ECG signals
Taşçı, B., Taşçı, G., Doğan, Ş., & Tuncer, T. (2022) · Cognitive Neurodynamics · doi:10.1007/s11571-022-09918-8 · Cited by 43
Gjerde, P. B., Dieset, I., Simonsen, C., Hoseth, E. Z., Iversen, T., Lagerberg, T. V., Lyngstad, S. H., Mørch, R. H., Skrede, S., Andreassen, O. A., et al. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2017.10.042 · Cited by 40 · cited 1×
“It was reported that the increased serum HDL-C levels with the use of antipsychotics that did not cause weight gain for one year after the first episode of psychosis reduced negative symptoms [28].”
BackgroundKanagasundaram, P., Lee, J., Prasad, F., Costa-Dookhan, K. A., Hamel, L., Gordon, M., Remington, G. J., Hahn, M., & Agarwal, S. M. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.642403 · Cited by 38 · cited 1×
“In a meta-analysis study investigating the effects of pharmacological interventions for the treatment of dyslipidemia because of antipsychotics in patients with schizophrenia, it was reported that the drugs used could decrease LDL-C, triglyceride, and total cholesterol levels while increasing HDL-C levels [29].”
BackgroundTaşçı, B., Acharya, M. R., Barua, P. D., Yıldız, A. M., Gün, M. V., Keleş, T., Doğan, Ş., & Tuncer, T. (2022) · Applied Acoustics · doi:10.1016/j.apacoust.2022.108897 · Cited by 32
Miller, B. J., Kandhal, P., Rapaport, M. H., Mellor, A., & Buckley, P. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.12.005 · Cited by 31 · cited 1×
“It was reported in a previous study that examined the relationship between inflammatory factors and cardiovascular diseases that WBC, CRP, and monocyte levels might be risk determinants for cardiovascular diseases [36].”
BackgroundSahpolat, M., Ayar, D., Ari, M., & Karaman, M. A. (2021) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2021.19.1.112 · Cited by 31
Automated ischemic acute infarction detection using pre-trained CNN models’ deep features
Taşçı, B. (2023) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2023.104603 · Cited by 31
Miller, G. E., Chen, E., Finegood, E. D., Shimbo, D., & Cole, S. W. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.11.003 · Cited by 21 · cited 1×
“In a two-year follow-up study examining inflammatory factors, which were considered to be effective on mental and physical development in children living in neighborhoods with high crime rates, it was found that systemic inflammatory response increased in these children, and monocytes mediated this increased response…”
BackgroundMonocyte/HDL ratio predicts hypertensive complications
Kaplan, I. G., Kaplan, M., Abacıoğlu, Ö. Ö., Yavuz, F., & Saler, T. (2020) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2020_018 · Cited by 14 · cited 1×
“It was also reported that it can be used to predict end-organ damage in hypertensive patients [14].”
BackgroundEvaluation of arterial stiffness in patients with schizophrenia
Baykara, S., Bozdağ, P. G., Baykara, M., & Namlı, M. N. (2020) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2020.07.008 · Cited by 14 · cited 1×
“In another study investigating arterial stiffness in schizophrenia patients, it was reported that these patients were more prone to develop arterial stiffness because of atherosclerosis, either because of the nature of the disease or the effect of antipsychotic treatment [35].”
BackgroundLipid profile in schizophrenia: case control study.
Mhalla, A., Salah, W. B. H., Mensi, R., Amamou, B., Messaoud, A., Gassab, L., Douki, W., Najjar, M. F., & Gaha, L. (2018) · PubMed · Cited by 9
Luquain‐Costaz, C., Kockx, M., Anastasius, M. O., Chow, V., Kontush, A., Jessup, W., & Kritharides, L. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.314847 · Cited by 9 · cited 1×
“It was reported in a previous study that was conducted in 2020 that there was an increase in the concentrations of atherogenic apoB-containing lipoproteins and a decrease in the concentrations of large HDL-C particles in schizophrenia patients [10].”
ResultA new dataset for EEG abnormality detection MTOUH
Taşçı, İ., Taşçı, B., Doğan, Ş., & Tuncer, T. (2022) · Turkish Journal of Science and Technology · doi:10.55525/tjst.1074540 · Cited by 6
The Monocyte/HDL Cholesterol Ratio in Obstructive Sleep Apnea Syndrome
Acat, M., & Yazıcı, O. (2018) · Meandros Medical And Dental Journal · doi:10.4274/meandros.galenos.2018.63935 · Cited by 5
Çakır, I., & Şimşek, Y. (2021) · Turkish Journal of Biochemistry · doi:10.1515/tjb-2021-0050 · Cited by 5 · cited 1×
“In another study that evaluated the effects of subclinical hyperthyroidism on lipids and inflammation markers in patients with newly diagnosed polycystic ovary syndrome, MHR was found to be high [17].”
BackgroundTaşçı, B. (2022) · Fırat Üniversitesi Mühendislik Bilimleri Dergisi · doi:10.35234/fumbd.1077322 · Cited by 5
Şizofreni’de inflamatuvar mekanizmaların yeri
Erkmen, T., Şahin, C., & Arıcıoğlu, F. (2015) · Dspace Repository (Marmara Üniversitesi) · Cited by 4
İpekçioğlu, D., & Kendirlioglu, B. K. (2019) · Bakirkoy Tip Dergisi / Medical Journal of Bakirkoy · doi:10.4274/btdmjb.galenos.2019.20190214042203 · Cited by 3 · cited 1×
“As the disease progresses in schizophrenia patients, the risk of cardiovascular disease increases because of an unhealthy lifestyle and poor eating habits, as well as the side effects of the antipsychotics used [31].”
BackgroundGüneş, H., Duksal, F., & Parlak, M. (2019) · Annals of Medical Research · doi:10.5455/annalsmedres.2019.05.249 · Cited by 3 · cited 1×
“, CRP, serum amyloid A, fibrinogen, erythrocyte sedimentation rate, and MHR) [18].”
BackgroundRelationship between elevated monocyte-HDL ratio, an inflammatory marker, with smoking
Köylü, E., & Kurtoğlu, Y. K. (2021) · The Journal of Turkish Family Physician · doi:10.15511/tjtfp.21.00022 · Cited by 3 · cited 1×
“However, it was reported that MHR is elevated in smoking individuals [38].”
Delibaş, D. H., Aydın, M., Kirkan, T. S., Oğuz, E. G., Karasu, U., Şimşek, Y., Kılıç, C., Ercan, S. K., Bayrakçı, A., Özçimen, A. T., et al. (2021) · Turkish Journal of Psychiatry · doi:10.5080/u25685 · Cited by 3 · cited 1×
“It was reported that life expectancy is shorter in schizophrenia patients when compared to the general population, and cardiovascular diseases are among the leading causes of mortality [33].”
BackgroundEfe, T. H., Arslan, E. D., Ertem, A. G., Yayla, Ç., Şahan, H. F., Felekoğlu, M. A., Algül, E., Genç, S., & Yeter, E. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.04.209 · Cited by 2 · cited 1×
“It was reported that it might be a prognostic factor predicting mortality in patients with acute pulmonary embolism [13].”
BackgroundCandemir, M., & Cansız, A. (2022) · Genel Tıp Dergisi · doi:10.54005/geneltip.1032165 · Cited by 2 · cited 2×
“It was reported that MHR is an important independent marker showing inflammation and oxidative stress in patients with schizophrenia and schizophrenia without the stable coronary disease [20].”
BackgroundKosovalı, B. D. (2020) · Abant Medical Journal · doi:10.47493/abantmedj.2020.4 · Cited by 1 · cited 1×
“It was also reported that MHR is elevated in patients with acute ischemic stroke and might be an indicator of chronic inflammation [19].”
Background
Research works printed but not linked: 2
- 2021, Comparison of Sleep Quality and Monocyte/High Density Lipoprotein Ratio by Physical Activity Level in Healthy Women, Kırıkkale Üniversitesi Tıp Fakültesi Derg., 23, 522
- First, 1987, Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P) New York: Biometrics Research, New York State Psychiatric Institute; 2002, Schizophr Bull., 13, 261
Cited by
Korkmaz, Ş. A., & Kızgın, S. (2023) · Current Medical Research and Opinion · doi:10.1080/03007995.2023.2260302 · Cited by 33
Dudeck, L., Nussbaumer, M., Nickl‐Jockschat, T., Guest, P. C., Dobrowolny, H., Meyer-Lotz, G., Zhao, Z., Jacobs, R., Schiltz, K., Fernandes, B. S., et al. (2025) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2024.4941 · Cited by 31
Nguyen, K. D., Amerio, A., Aguglia, A., Magnani, L., Parise, A., Conio, B., Serafini, G., Amore, M., & Costanza, A. (2023) · Cells · doi:10.3390/cells12162099 · Cited by 14
“Monocytes Increased total monocyte counts [62–64] Increased classical monocyte counts [66] Increased pro-inflammatory monocyte counts [67] Increased monocyte to lymphocyte ratio [68] Increased monocyte to HDL ratio [72,73] Increased TREM1/2 [79,80] Increased ATF3/EGR3 [78] Increased HLA-DR [82] Increased phagocytosis…”
BackgroundChen, L., Zheng, C., Luan, H., & Chen, X. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s473528 · Cited by 10
“24,37 Our study extends these findings by revealing consistent dysregulation of MON counts and HDL levels across different illness stages, showing increased monocytes, HDL, and MHR observed in both AN-FES and CS groups.”
BackgroundNon-diabetic elderly populations: the MHR as a protective factor against bone abnormalities
Li, X., Yan, M., Ji, J., & Ma, Z. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1408467 · Cited by 9
Metadata
- Authors
- Kılıç, N., Tasci, G., Yılmaz, S., Öner, P., & Korkmaz, S.
- Affiliations
- Elazığ Fethi Sekin City Hospital, Department of Psychiatry, Elazığ 23100, Türkiye
- Elazığ Fethi Sekin City Hospital, Department of Microbiology, Elazığ 23100, Türkiye
- Fırat University (TR)
- Venue
- Journal of Personalized Medicine
- Publisher
- MDPI AG
- Published
- 2023-01-31
- Volume
- 13
- Issue
- 2
- Pages
- 276
- ISSN
- 2075-4426 (ISSN-L)
- PMC
- PMC9958934
- OpenAlex
- W4318829874
- Cited by
- 15
- References
- 44
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 3 · 2023: 4
- FWCI
- 3.04
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Personalized Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DSpace - FIRAT (Fırat University) (submittedVersion, cc-by-nc-nd)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Keywords
- schizophrenia, inflammation, inflammatory markers, cardiovascular risk, HDL cholesterol, monocytes, lipid profile, white blood cell count, schizophrenia pathophysiology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
